News
Regeneron Just Bought Your DNA From 23andMe
Digest more
The partnership is poised to increase patient impact, especially for those who would benefit from enhanced care co-ordination ...
The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.
Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...
1don MSN
It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...
Thank you for your interest in Regeneron and welcome to our first quarter 2025 earnings conference call. An archive and transcript of this call will be available on Regeneron's Investor ...
Morning! Today we start with some breaking newss: Novo Nordisk’s CEO is stepping down. We also discuss a new, tailored CRISPR treatment for an infant with a deadly disease, how Amgen owes Regeneron ...
Fintel on MSN6d
Citigroup Upgrades Regeneron Pharmaceuticals (REGN)Fintel reports that on May 14, 2025, Citigroup upgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback